OPIOID AND PRESCRIPTION DRUG ABUSE
|Coronavirus (COVID-19)||Medication Therapy Management (MTM)||Immunizations||Statewide Naloxone CPP||Pharmacist-Provided Hormonal Contraceptives|
|Pharmacist Credentialing, Contracting, and Billing||Point of Care Testing||Collaborative Pharmacy Practice||Pharmacy Benefits Manager (PBM) Laws||Opioid and Prescription Drug Abuse|
CLICK HERE –to access the “Opioid and Prescription Drug Abuse” resources listed below — EXCLUSIVELY FOR TPA MEMBERS.
In 2016, Tennessee had the 2nd highest prescription rate for opioids and was ranked near the top in prescription opioid overdose deaths per capita in the US, with 1,631 deaths in that year alone. Abuse of prescription benzodiazepines, stimulants, and sedatives has also become a growing concern.
While the federal and state governments are implementing policies in hopes of solving this national epidemic, pharmacists and health care providers continue to fight the battle against prescription drug abuse on the front lines. The Tennessee Pharmacists Association (TPA) has published this resource page to help pharmacists balance legitimate need and patient access with prevention of prescription drug abuse.